Posted in | Nanomedicine | Nanobusiness

Comprehensive Report on US Nanotechnology Drug Delivery Market

Published on June 19, 2013 at 3:34 AM

Research and Markets has announced the addition of the "Nanotechnology Drug Delivery Market in the US 2012-2016" report to their offering.

Nanotechnology Drug Delivery Market In The Us Expected To Grow At A CAGR Of 84.79 Percent Over The Period 2012-2016

TechNavio's report, the Nanotechnology Drug Delivery Market in the US 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. It also covers the Nanotechnology Drug Delivery market in the US landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Commenting on the report, an analyst from TechNavio's Healthcare team said: 'Over the years, the research activities in healthcare have changed significantly. There has been a paradigm shift away from blockbusters drugs to a more personalized medicine approach. The focus is being placed increasingly on formulating drugs based on the individual's unique genome and immune response. Personalized medicines have gained significant popularity because they enable the medical profession to provide customized treatment to patients. A customized treatment is based on the genetic as well as medical profile of a patient. Increasing knowledge about the molecular causes of diseases is increasing the demand for more targeted and effective nanotechnology-enabled drug delivery therapies.'

According to the report, one of the most important applications of nanotechnology in medicine currently being developed involves employing nanoparticles to deliver drugs to specific types of cells (such as cancer cells). Nanotechnology drug delivery helps in delivering drugs directly to diseased cells, which allows direct treatment of those cells. This technique helps to avoid damage to healthy cells within the human body. Hence, drug delivery technology helps to increase the overall market success of a particular drug.

Key Questions Answered

  • What will the market size be in 2016 and at what will be the growth rate?
  • What are key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by key vendors?
  • What are the strengths and weaknesses of each of these key vendors?

Key Topics Covered

1. Executive Summary

2. List of Abbreviations

3. Introduction

4. Scope of the Report

5. Market Landscape

6. Vendor Landscape

7. Buying Criteria

8. Market Growth Drivers

9. Drivers and their Impact

10. Market Challenges

11. Impact of Drivers and Challenges

12. Market Trends

13. Key Vendor Analysis

Examples of Companies Mentioned

  • Alkermes
  • Amgen
  • Angiotech Pharmaceuticals
  • Biophan Technologies
  • Calando Pharmaceuticals
  • Celgene
  • Cephalon
  • Cerulean Pharma
  • CritiTech
  • CytImmune Sciences
  • Debiotech
  • Elan Corp.
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • IOTA NanoSolutions
  • Lena Nanoceutics
  • Merck & Co.
  • Merck Sharp & Dohme
  • Nano Interface Technology
  • NanoBioMagnetics
  • NanoCarrier
  • NanoSight
  • Nanotherapeutics
  • Novartis
  • Novavax
  • Particle Sciences
  • Pfizer
  • SoluBest
  • Spherics

For more information visit http://www.researchandmarkets.com/research/m3p4vl/nanotechnology

Source: http://www.researchandmarkets.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit